| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004040452A1 Peptidgemisch Peptide mixture |
| 02/23/2006 | DE102004039280A1 1,5-Diphenyl-pyrazole 1,5-diphenyl-pyrazoles |
| 02/23/2006 | CA2578189A1 Method for determining dosage for an oral killed vaccine |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2577183A1 Mutated hiv nef for modulating immunity |
| 02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 02/23/2006 | CA2576042A1 Immune stimulatory infant nutrition |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627871A1 Cyclic aminophenyl sulfamate derivative |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627640A1 Sulfate group transferase inhibitor |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1627055A2 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1208086B1 Benzamide formulation with histone deacetylase inhibitor activity |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0907378B1 Method for the concentration of antibody solutions |
| 02/22/2006 | CN1738825A Thienopyridazinones and their use in modulation of autoimmune disease |
| 02/22/2006 | CN1738632A Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738601A Dermastick thickened ointment |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1738595A Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 02/22/2006 | CN1736488A Method for preparing nanometer sized rapamycin/chitosan enveloped carrier |
| 02/22/2006 | CN1736483A Use of a CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/22/2006 | CN1736476A Transfer factor powder spray and preparation process thereof |
| 02/22/2006 | CN1736462A Chinese proprietary medicine making fleece-flower root as main raw material |
| 02/22/2006 | CN1736386A Pharmaceutical formulation for treating skin allergy and preparation process thereof |
| 02/22/2006 | CN1243093C Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/22/2006 | CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242807C Pharmaceutical composition for resisting allergic reaction and its preparing process and use |
| 02/22/2006 | CN1242781C Medicine for treating urticaria |
| 02/22/2006 | CN1242744C Nasal cavity preparation for treating long-term allergic reaction coryza |
| 02/22/2006 | CN1242695C Health food capable of raising organism immune power and its preparation method |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7002012 Therapeutic treatment of septic shock; chemical condensation reaction by cyclization, amidation, chemical intermediates |
| 02/21/2006 | US7002009 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine; diffraction peaks at diffraction angles in a powder X-ray diffraction pattern; pure, stable crystal |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 02/21/2006 | US7001775 associated with autoimmune thyroid disease; colorimetric immunoassay; contacting fluids with immobilized antibodies, labeling and monitoring; simple, rapid |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2337846C Polymorph of ritonavir |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006015886A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | WO2006015861A2 Drop preparations comprising dimetindene |
| 02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | WO2005048957A3 Novel insertion sites in pox vectors |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060036420 Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035973 Pharmaceutical composition for intracellular acidification with cis-urocanic |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035919 4-[4-(4-Amino-phenyl)-3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl]-benzoic acid methyl ester; rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis; CD80 antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035809 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035263 DRG11-responsive (DRAGON) gene family |
| 02/16/2006 | US20060035221 Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis |
| 02/16/2006 | US20060034957 Vitamin-containing system for stabilising the immune response of animals |
| 02/16/2006 | US20060034951 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/16/2006 | US20060034928 Tablet comprising cetirizine and pseudoephedrine |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034856 Epha2 antigen t epitopes |
| 02/16/2006 | US20060034855 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 02/16/2006 | US20060034854 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 02/16/2006 | US20060034834 Intrabody-mediated control of immune reactions |
| 02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 02/16/2006 | US20060034817 Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase |
| 02/16/2006 | US20060034811 Melanoma vaccine and methods of making and using same |
| 02/16/2006 | US20060034781 Peroral preparation for prevention or treatment of atopic dermatatis |